Abstract
We have developed a simple NMR-based method to determine the turnover of nucleotides and incorporation into RNA by stable isotope resolved metabolomics (SIRM) in A549 lung cancer cells. This method requires no chemical degradation of the nucleotides or chromatography. During cell growth, the free ribonucleotide pool is rapidly replaced by de novo synthesized nucleotides. Using [U-13C]-glucose and [U-13C,15N]-glutamine as tracers, we showed that virtually all of the carbons in the nucleotide riboses were derived from glucose, whereas glutamine was preferentially utilized over glucose for pyrimidine ring biosynthesis, via the synthesis of Asp through the Krebs cycle. Incorporation of the glutamine amido nitrogen into the N3 and N9 positions of the purine rings was also demonstrated by proton-detected 15N NMR. The incorporation of 13C from glucose into total RNA was measured and shown to be a major sink for the nucleotides during cell proliferation. This method was applied to determine the metabolic action of an anti-cancer selenium agent (methylseleninic acid or MSA) on A549 cells. We found that MSA inhibited nucleotide turnover and incorporation into RNA, implicating an important role of nucleotide metabolism in the toxic action of MSA on cancer cells.
Similar content being viewed by others
Abbreviations
- DSS:
-
2,2′-Dimethylsilapentane-5-sulfonate
- GSH:
-
Reduced glutathione
- HSQC:
-
Heteronuclear single quantum coherence
- MSA:
-
Methyl seleninic acid
- NSCLC:
-
Non small cell lung cancer
- SIRM:
-
Stable isotope resolved metabolomics
- TOCSY:
-
Total correlation spectroscopy
References
Bak, L. K., Waagepetersen, H. S., Melo, T. M., Schousboe, A., & Sonnewald, U. (2007). Complex glutamate labeling from [U-C-13]glucose or [U-C-13]lactate in co-cultures of cerebellar neurons and astrocytes. Neurochemical Research, 32, 671–680.
Beger, R. D., Hansen, D. K., Schnackenberg, L. K., Cross, B. M., Fatollahi, J. J., Lagunero, F. T., et al. (2009). Single valproic acid treatment inhibits glycogen and RNA ribose turnover while disrupting glucose-derived cholesterol synthesis in liver as revealed by the [U-13C6]-d-glucose tracer in mice. Metabolomics, 5, 336–345.
Boren, J., Cascante, M., Marin, S., Comin-Anduix, B., Centelles, J. J., Lim, S., et al. (2001). Gleevec (ST1571) influences metabolic enzyme activities and glucose carbon flow toward nucleic acid and fatty acid synthesis in myeloid tumor cells. Journal of Biological Chemistry, 276, 37747–37753.
Centelles, J. J., Ramos-Montoya, A., Lim, S., Bassilian, S., Boros, L. G., Marin, S., et al. (2007). Metabolic profile and quantification of deoxyribose synthesis pathways in HepG2 cells. Metabolomics, 3, 105–111.
Clark, L. C., Combs, G. F., Turnbull, B. W., Slate, E. H., Chalker, D. K., Chow, J., et al. (1996). Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin a randomized controlled trial—A randomized controlled trial. Journal of the American Medical Association (JAMA), 276, 1957–1963.
Combs, G. F. (2004). Status of selenium in prostate cancer prevention. British Journal of Cancer, 91, 195–199.
DeBerardinis, R. J., Mancuso, A., Daikhin, E., Nissim, I., Yudkoff, M., Wehrli, S., et al. (2007). Beyond aerobic glycolysis: Transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis. Proceedings of the National Academy of Sciences, 104, 19345–19350.
Delgado, T. C., Castro, M. M., Geraldes, C. F., & Jones, J. G. (2004). Quantitation of erythrocyte pentose pathway flux with [2-(13)]glucose and H-1 NMR analysis of the lactate methyl signal. Magnetic Resonance in Medicine, 51, 1283–1286.
Fan, T. W.-M. & Lane, A. N. (2011a). Assignment strategies for NMR resonances in metabolomics research. In N. Lutz, J. V. Sweedler & Dr. R. A. Wever (Eds.), Methodologies for metabolomics: Experimental strategies and techniques. New York: Cambridge University Press (in press).
Fan, T. W.-M., & Lane, A. N. (2008). Structure-based profiling of metabolites and isotopomers by NMR. Progress in NMR Spectroscopy, 52, 69–117.
Fan, T. W. -M., & Lane, A. N. (2011b). NMR-based stable isotope resolved metabolomics in systems biochemistry. Journal of Biomolecular NMR, 49(3–4), 267–280.
Fan, T. W. M., Higashi, R. M., Lane, A. N., & Jardetzky, O. (1986). Combined use of proton NMR and gas chromatography-mass spectra for metabolite monitoring and in vivo proton NMR assignments. Biochimica et Biophysica Acta, 882, 154–167.
Fan, T. W.-M., Bandura, L., Higashi, R. M., & Lane, A. N. (2005). Metabolomics-edited transcriptomics analysis of Se anticancer action in human lung cancer cells. Metabolomics, 1, 1–15.
Fan, T. W. M., Higashi, R. M., & Lane, A. N. (2006). Integrating metabolomics and transcriptomics for probing Se anticancer mechanisms. Drug Metabolism Reviews, 38, 707–732.
Fan, T. W.-M., Kucia, M., Jankowski, K., Higashi, R. M., Rataczjak, M. Z., Rataczjak, J., et al. (2008). Proliferating rhabdomyosarcoma cells shows an energy producing anabolic metabolic phenotype compared with primary myocytes. Molecular Cancer, 7, 79.
Fan, T. W.-M., Lane, A. N., Higashi, R. M., Farag, M. A., Gao, H., Bousamra, M., et al. (2009). Altered regulation of metabolic pathways in human lung cancer discerned by 13C stable isotope-resolved metabolomics (SIRM)). Molecular Cancer, 8, 41.
Fan, T. W.-M., Yuan, P., Lane, A. N., Higashi, R. M., Wang, Y., Hamidi, A., et al. (2010). Stable isotope resolved metabolomic analysis of lithium effects on glial-neuronal interactions. Metabolomics, 6, 165–179.
Ganther, H. E. (1999). Selenium metabolism, selenoproteins and mechanisms of cancer prevention: Complexities with thioredoxin reductase. Carcinogenesis (Oxford), 20, 1657–1666.
Hiller, K., Metallo, C. M., Kelleher, J. K., & Stephanopoulos, G. (2010). Nontargeted elucidation of metabolic pathways using stable-isotope tracers and mass spectrometry. Analytical Chemistry, 82, 6621–6628.
Hu, V. W., Black, G. E., Torres-Duarte, A., & Abramson, F. P. (2002). H-3-thymidine is a defective tool with which to measure rates of DNA synthesis. FASEB Journal, 16(11), 1456–1457.
Ip, C., Dong, Y., & Ganther, H. E. (2002). New concepts in selenium chemoprevention. Cancer and Metastasis Reviews, 21, 281–289.
Ippel, J., Wijmenga, S., de Jong, B., Heus, H., Hilbers, C., Vroom, E., et al. (1996). Heteronuclear scalar couplings in the bases and sugar rings of nucleic acids: Their determination and application in assignment and conformational analysis. Magnetic Resonance in Chemistry, 34, S156–S176.
Lane, A. N., & Fan, T. W.-M. (2007). Quantification and identification of isotopomer distributions of metabolites in crude cell extracts using 1H TOCSY. Metabolomics, 3, 79–86.
Lane, A. N., Fan, T. W.-M., & Higashi, R. M. (2008). Isotopomer-based metabolomic analysis by NMR and mass spectrometry. Biophysical Tools for Biologists, 84, 541–588.
Lane, A. N., Fan, T. W.-M., Higashi, R. M., Tan, J., Bousamra, M., & Miller, D. M. (2009). Prospects for clinical cancer metabolomics using stable isotope tracers. Journal of Experimental Molecular Pathology, 86, 165–173.
Lippman, S. M., Klein, E. A., Goodman, P. J., Lucia, M. S., Thompson, I. M., Ford, L. G., et al. (2009). Effect of selenium and vitamin e on risk of prostate cancer and other cancers: The selenium and vitamin E cancer prevention trial (SELECT). Journal of the American Medical Association (JAMA), 301, 39–51.
Lu, X., Bennet, B., Mu, E., Rabinowitz, J., & Kang, Y. (2010). Metabolomic changes accompanying transformation and acquisition of metastatic potential in a syngeneic mouse mammary tumor model. Journal of Biological Chemistry, 285, 9317–9321.
Mancuso, A., Zhu, A. Z., Beardsley, N. J., Glickson, J. D., Wehrli, S., & Pickup, S. (2005). Artificial tumor model suitable for monitoring P-31 and C-13 NMR spectroscopic changes during chemotherapy-induced apoptosis in human glioma cells. Magnetic Resonance in Medicine, 54, 67–78.
Mason, G. F., Petersen, K. F., de Graaf, R. A., Shulman, G. I., & Rothman, D. L. (2007). Measurements of the anaplerotic rate in the human cerebral cortex using C-13 magnetic resonance spectroscopy and [1-C-13] and [2-C-13] glucose. Journal of Neurochemistry, 100, 73–86.
Mendes, A. C., Caldeira, M. M., Silva, C., Burgess, S. C., Merritt, M. E., Gomes, F., et al. (2006). Hepatic UDP-glucose C-13 isotopomers from [U-C-13]glucose: A simple analysis by C-13 NMR of urinary menthol glucuronide. Magnetic Resonance in Medicine, 56, 1121–1125.
Morrish, F., Isern, N., Sadilek, M., Jeffrey, M., & Hockenbery, D. M. (2009). c-Myc activates multiple metabolic networks to generate substrates for cell-cycle entry. Oncogene, 28, 2485–2491.
Moseley, H. N. B., Lane, A. N., Belshoff, A. C., Higashi, R. M., & Fan, W. W.-M. (2011). Non-steady state modeling of UDP-GlcNAc biosynthesis is enabled by stable isotope resolved metabolomics (SIRM). BMC Biology, 9, 37.
Murray, R. K., Bender, D. A., Botham, K. M., Kennelly, P. J., Rodwell, V. W., & Weil, P. A. (2009). Harper’s illustrated biochemistry. New York: McGraw-Hill.
Nelson, D. L., & Cox, M. M. (2005). Lehninger principles of biochemistry. New York: W.H. Freeman and Company.
Telang, S., Lane, A. N., Nelson, K. K., Arumugam, S., & Chesney, J. A. (2007). The oncoprotein H-RasV12 increases mitochondrial metabolism. Molecular Cancer, 6, 77.
Vizan, P., Boros, L. G., Figueras, A., Capella, G., Mangues, R., Bassilian, S., et al. (2005). K-ras codon-specific mutations produce distinctive metabolic phenotypes in human fibroblasts. Cancer Research, 65, 5512–5515.
Vizan, P., Alcarraz-Vizan, G., Diaz-Moralli, S., Rodriguez-Prados, J. C., Zanuy, M., Centelles, J. J., et al. (2007). Quantification of intracellular phosphorylated carbohydrates in HT29 human colon adenocarcinoma cell line using liquid chromatography-electrospray ionization tandem mass spectrometry. Analytical Chemistry, 79, 5000–5005.
Yuneva, M. (2008). Finding an “Achilles’ heel” of cancer: the role of glucose and glutamine metabolism in the survival of transformed cells. Cell Cycle, 7, 2083–2089.
Zwingmann, C., & Leibfritz, D. (2003). Regulation of glial metabolism studied by C-13-NMR. NMR in Biomedicine, 16, 370–399.
Acknowledgments
The authors thank Dr. S. Arumugam for assistance in the NMR measurements. This study was supported in part by National Science Foundation EPSCoR grant # EPS-0447479; NIH NCRR Grant 5P20RR018733, 1R01CA118434-01A2 (to TWMF), 1RO1 CA101199 (to TWMF), R21CA133668-01 (to ANL) from the National Cancer Institute; the Kentucky Challenge for Excellence, and the Brown Foundation.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
11306_2011_337_MOESM1_ESM.doc
Figure S1. Effect of MSA on 13C incorporation from [U-13C]-glucose into the ribose subunit of A549 RNA. A549 cells were grown in [U-13C]-glucose in the absence or presence of MSA. Total RNA was extracted and digested for 2-D 1H TOCSY NMR analysis in terms of fractional (%) 13C enrichment in C1’ of AMP ribose as described in the methods. Each data point represents an average of two replicates. Red: control, Blue: +5 μM MSA. (DOC 85 kb)
Rights and permissions
About this article
Cite this article
Fan, T.WM., Tan, J., McKinney, M.M. et al. Stable isotope resolved metabolomics analysis of ribonucleotide and RNA metabolism in human lung cancer cells. Metabolomics 8, 517–527 (2012). https://doi.org/10.1007/s11306-011-0337-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11306-011-0337-9